Perioperative Piperacillin/Tazobactam Reduces Early Onset SSI in Preirradiated Patients Undergoing Microvascular Head and Neck Reconstruction

Documenti analoghi

• A Comprehensive Immune Checkpoint Phenotype Predicts Response and Survival to PD ‐1 Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
  di: Mathias Fiedler, et al.
  Pubblicazione: (2026)
• Increased PD‐1/PD‐L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never‐Smokers and Never‐Drinkers
  di: Mathias Fiedler, et al.
  Pubblicazione: (2024)
• Airway Management in Microvascular Reconstruction of the Head and Neck: Current Practice Patterns
  di: Rotem Kimia, et al.
  Pubblicazione: (2024)
• Racial Disparities in Perioperative Outcomes for Patients With Head and Neck Cancer
  di: Soraya Fereydooni, et al.
  Pubblicazione: (2024)
• Inpatient Opioid Use in Head and Neck Microvascular Free Flap Reconstruction
  di: Patricia Timothee, et al.
  Pubblicazione: (2026)